Search results for "GiST"

showing 10 items of 3463 documents

Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions

2015

Background Through contemporary literature, the optimal strategy to manage coronary chronic total occlusions (CTOs) remains under debate. Objectives The aim of the Italian Registry of Chronic Total Occlusions (IRCTO) was to provide data on prevalence, characteristics, and outcome of CTO patients according to the management strategy. Methods The IRCTO is a prospective real world multicentre registry enrolling patients showing at least one CTO. Clinical and angiographic data were collected independently from the therapeutic strategy [optimal medical therapy (MT), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG)]; a comparative 1-year clinical followup was pe…

Malemedicine.medical_specialtymedicine.medical_treatmentLeftCoronary AngiographyVentricular Dysfunction LeftCoronary artery bypass surgeryPercutaneous Coronary InterventionInternal medicineVentricular DysfunctionPrevalenceHumansMedicineProspective StudiesRegistriesMyocardial infarctionCoronary Artery BypassProspective cohort studyCABGAgedbusiness.industryChronic total occlusion † Registry † PCI † CABG † Optimal medical therapyPercutaneous coronary interventionCardiovascular AgentsPCImedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareChronic total occlusionTreatment Outcomemedicine.anatomical_structureCoronary OcclusionItalyCoronary occlusionChronic total occlusion; PCI; CABGChronic DiseaseCardiovascular agentConventional PCICardiologyFemaleCardiology and Cardiovascular MedicinebusinessArteryEuropean Heart Journal
researchProduct

Impact of Atrial Fibrillation on Postoperative Adverse Outcomes of Surgical Patients With Knee Endoprosthetic Surgery

2018

Atrial fibrillation/flutter (AF) is associated with increased mortality, thromboembolism, heart failure, and adverse perioperative outcomes. We aimed to investigate the impact of AF on adverse in-hospital outcomes of hospitalized patients who underwent knee endoprosthetic surgery (KES).The nationwide German inpatient sample of the years 2005-2015 was used for this analysis. Patients who underwent KES were identified based on the surgical and interventional procedural codes (surgery and procedure code [Operationen-und Prozedurenschlüssel] 5-822), and patients were further stratified by AF (International Classification of Diseases and Related Health Problems code I48). We compared patients wi…

Malemedicine.medical_specialtymedicine.medical_treatmentMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsCause of DeathGermanyThromboembolismAtrial FibrillationOdds RatiomedicineHumansOrthopedics and Sports MedicineHospital MortalityPostoperative Period030212 general & internal medicineMyocardial infarctionArthroplasty Replacement KneeStrokeAgedHeart FailureInpatientsbusiness.industryAtrial fibrillationPerioperativeLength of StayMiddle Agedmedicine.diseaseArthroplastyPulmonary embolismSurgeryStrokeLogistic ModelsRelative riskHeart failureFemalebusinessThe Journal of Arthroplasty
researchProduct

Five-Year Survival in Patients With ST-Segment–Elevation Myocardial Infarction According to Modalities of Reperfusion Therapy

2014

Background— Although primary percutaneous coronary intervention (pPCI) is the preferred reperfusion method for ST-segment–elevation myocardial infarction, it remains difficult to implement in many areas, and fibrinolytic therapy is still widely used. Methods and Results— We assessed 5-year mortality in patients with ST-segment–elevation myocardial infarction from the French Registry of Acute ST-Elevation or Non-ST Elevation Myocardial Infarction (FAST-MI) 2005 according to use and type of reperfusion therapy. Of 1492 patients with ST-segment–elevation myocardial infarction with a first call ≤12 hours from onset, 447 (30%) received fibrinolysis (66% prehospital; 97% with subsequent angiogra…

Malemedicine.medical_specialtymedicine.medical_treatmentMyocardial InfarctionMyocardial Reperfusion030204 cardiovascular system & hematologyCohort Studies03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicineReperfusion therapyFibrinolytic AgentsPhysiology (medical)Internal medicineFibrinolysisHumansMedicineST segmentRegistries030212 general & internal medicineMyocardial infarctionAgedAged 80 and overbusiness.industryST elevationHazard ratioPercutaneous coronary interventionMiddle Agedmedicine.disease3. Good healthSurgerySurvival RateTreatment OutcomeConventional PCICardiologyFemaleFranceCardiology and Cardiovascular MedicinebusinessCirculation
researchProduct

Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Span…

2021

Allogeneic hematopoietic cell transplantation (allo-HCT) is increasingly used in older myelofibrosis (MF) patients, but its risk/benefit ratio compared to non-transplant approaches has not been evaluated in this population. We analyzed the outcomes of allo-HCT in 556 MF patients aged > 65years from the EBMT registry, and determined the excess mortality over the matched general population of MF patients > 65years managed with allo-HCT (n=556) or conventional drug treatment (n=176). The non-transplant cohort included patients with intermediate-2 or high risk DIPSS from the Spanish Myelofibrosis Registry. After a median follow-up of 3.4years, the estimated 5-year survival rate, non-relapse mor…

Malemedicine.medical_specialtymedicine.medical_treatmentPopulationMedizinHematopoietic stem cell transplantationCohort StudiesInternal medicinemedicineHumansTransplantation HomologousRegistrieseducationSurvival rateSurvival analysisAgededucation.field_of_studybusiness.industryAge FactorsHematopoietic Stem Cell TransplantationHematologySurvival AnalysisTransplantationPrimary MyelofibrosisSpainCohortFemalebusinessBusulfanCohort studymedicine.drug
researchProduct

Mortality of patients with ST-segment elevation myocardial infarction and cardiogenic shock treated by PCI is correlated to the infarct-related arter…

2011

Background: Mortality of patients with ST-segment elevation myocardial infarction (STEMI) with cardiogenic shock (CS) on admission remains high despite invasive treatment. The aim of this analysis was to assess the relationship between the infarct-related artery (IRA) and the early and 12-month outcomes of patients with STEMI and CS treated by percutaneous coronary intervention (PCI). Methods: Two thousand ninety patients with STEMI and CS registered in the prospective Polish Registry of Acute Coronary Syndromes from October 2003 to November 2009 were included. Results: The in-hospital mortality in the left main (LM), left anterior descending artery (LAD), circumflex artery (Cx), and right …

Malemedicine.medical_specialtymedicine.medical_treatmentShock CardiogenicPercutaneous coronary interventionInternal medicinemedicine.arterymedicineHumansST segmentHospital MortalityProspective StudiesRegistriescardiovascular diseasesCircumflexMyocardial infarctionCardiogenic shockAgedbusiness.industryCardiogenic shockPercutaneous coronary interventionMiddle Agedmedicine.diseaseCoronary VesselsMyocardial infarctionTreatment Outcomesurgical procedures operativeShock (circulatory)Right coronary arteryConventional PCICardiologyFemalePolandmedicine.symptomCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Assessment of quality of care of patients with ST-segment elevation myocardial infarction

2020

Aims:The 2017 European Society of Cardiology guidelines for the management of ST-elevation myocardial infarction recommended assessing quality of care to establish measurable quality indicators in order to ensure that every ST-elevation myocardial infarction patient receives the best possible care. We investigated the quality indicators of healthcare services in Poland provided to ST-elevation myocardial infarction patients.Methods and results:The Polish Registry of Acute Coronary Syndromes is a nationwide, multicentre, prospective study of acute coronary syndrome patients in Poland. For the purpose of assessing quality indicators, we included 8279 patients from the Polish Registry of Acute…

Malemedicine.medical_specialtymedicine.medical_treatmentacute myocardial infarctionQuality indicatorshealthcare system performance030204 cardiovascular system & hematologyCoronary AngiographyCritical Care and Intensive Care MedicineElectrocardiography03 medical and health sciences0302 clinical medicineReperfusion therapyPatient Self-ReportRisk FactorsOutcome Assessment Health CareHumansMedicineST segmentProspective StudiesRegistries030212 general & internal medicineMyocardial infarctionQuality of careAgedQuality of Health CareEjection fractionbusiness.industryPercutaneous coronary interventionGeneral MedicineMiddle Agedmedicine.diseasemortalityHeart failureEmergency medicineST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal. Acute Cardiovascular Care
researchProduct

Association between Obesity History and Hand Grip Strength in Older Adults-Exploring the Roles of Inflammation and Insulin Resistance as Mediating Fa…

2011

Background: To examine the association between obesity history and hand grip strength, and whether the association is partly explained by subclinical inflammation and insulin resistance. Methods:Data are from 2,021 men and women aged 55 years and older participating in the representative population-based Health 2000 Survey in Finland. Body mass and body height, maximal hand grip strength, C-reactive protein, and insulin resistance based on homeostasis model assessment (HOMA-IR) were measured in a health examination. Recalled weight at 20, 30, 40, and 50 years of age were recorded to obtain a hierarchical classification of obesity history. Obesity was defined as body mass index ≥ 30 kg/m2. R…

Malemedicine.medical_specialtyobesityAgingLogistic regressionBody Mass IndexGrip strengthInsulin resistanceSDG 3 - Good Health and Well-beingRisk FactorsInternal medicineHand strengthinsulin resistancemedicineHumansObesityProspective cohort studyFinlandAgedInflammationHand Strengthbusiness.industryMuscle strengthagingInsulin resistanceMiddle Agedmedicine.diseaseObesityConfidence intervalBody HeightC-Reactive ProteininflammationPhysical therapyJournal of Gerontology: MEDICAL SCIENCES/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemaleGeriatrics and GerontologybusinessBody mass index
researchProduct

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

2021

Abstract Background and Aims The development programm UNIFI has shown promising results of ustekinumab in ulcerative colitis [UC] treatment which should be confirmed in clinical practice. We aimed to evaluate the durability, effectiveness, and safety of ustekinumab in UC in real life. Methods Patients included in the prospectively maintained ENEIDA registry, who received at least one intravenous dose of ustekinumab due to active UC [Partial Mayo Score [PMS]>2], were included. Clinical activity and effectiveness were defined based on PMS. Short-term response was assessed at Week 16. Results A total of 95 patients were included. At Week 16, 53% of patients had response [including 35% o…

Malemedicine.medical_specialtyustekinumabVedolizumab03 medical and health sciences0302 clinical medicineremissionColitis ulcerosaInternal medicineUstekinumabHumansMedicineProspective StudiesRegistriesInfusions IntravenousAdverse effectreal-world evidenceAcademicSubjects/MED00260ulcerative colitisTofacitinibresponsebiologybusiness.industryRemission InductionC-reactive proteinGastroenterologyGeneral MedicineMiddle Agedmedicine.diseaseUlcerative colitisDiscontinuation030220 oncology & carcinogenesisCohortbiology.proteindurabilityOriginal ArticleColitis UlcerativeFemaleMonoclonal antibodies030211 gastroenterology & hepatologyUstekinumabbusinessAnticossos monoclonalsmedicine.drug
researchProduct

Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke

2016

Background and Purpose— We compared outcome and complications in patients with stroke treated with intravenous thrombolysis (IVT) who could not live alone without help of another person before stroke (dependent patients) versus independent ones. Methods— In a multicenter IVT-register–based cohort study, we compared previously dependent (prestroke modified Rankin Scale score, 3–5) versus independent (prestroke modified Rankin Scale score, 0–2) patients. Outcome measures were poor 3-month outcome (not reaching at least prestroke modified Rankin Scale [dependent patients]; modified Rankin Scale score of 3–6 [independent patients]), death, and symptomatic intracranial hemorrhage. Unadjusted an…

Malemedicine.medical_treatment030204 cardiovascular system & hematologylaw.inventionCohort Studies0302 clinical medicineRandomized controlled triallawModified Rankin ScaleActivities of Daily Living80 and overThrombolytic TherapyRegistriesStrokeriskAged 80 and overpreexisting disabilityMedicine (all)survivorsThrombolysisMiddle Aged3. Good healthStrokeTreatment OutcomeInfusions intravenous; Intracranial hemorrhages; Outcome assessment (health care); Stroke; Survivors; Administration Intravenous; Aged; Aged 80 and over; Cohort Studies; Female; Humans; Logistic Models; Male; Middle Aged; Stroke; Treatment Outcome; Activities of Daily Living; Independent Living; Registries; Thrombolytic Therapy; Medicine (all); Neurology (clinical); Cardiology and Cardiovascular Medicine; Advanced and Specialized Nursingcontrolled-trialAdministration[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Administration IntravenousFemaleIndependent Livingacute ischemic-strokehemorrhageCardiology and Cardiovascular MedicineCohort studymedicine.medical_specialtyintracranial hemorrhagesstatinsscale03 medical and health sciencesInternal medicinemedicineHumansDementiaAgedoutcome assessment (health care)Advanced and Specialized Nursingreliabilitybusiness.industryOdds ratiomedicine.diseaseConfidence intervalinfusionsSurgeryLogistic Models[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]intravenousiv thrombolysisNeurology (clinical)business030217 neurology & neurosurgeryStroke
researchProduct

Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy.

2017

Background. Optimal modalities for diagnosis, treatment, and surveillance of portal or splenic vein thrombosis have not yet been defined. The present retrospective study aimed to investigate the role of computed tomography performed systematically before and after laparoscopic splenectomy to assess the incidence of portal or splenic vein thrombosis, predictors, and outcomes. Methods. Computed tomography scans were obtained from 170 patients undergoing elective laparoscopic splenectomy between 2005 and 2015. Pre- and postoperative splenic vein diameter was measured at the splenoportal junction and at a distance of 2, 4, 6 cm from it. Univariate and multivariate analyses were used to identify…

Malemedicine.medical_treatment030230 surgery0302 clinical medicinePostoperative ComplicationsRisk FactorsLaparoscopyAged 80 and overVenous Thrombosismedicine.diagnostic_testPortal VeinIncidenceMiddle Agedsplenic vein thrombosiTreatment Outcomecardiovascular systemSplenectomy030211 gastroenterology & hepatologyFemaleRadiologymedicine.symptomAdultmedicine.medical_specialtyAdolescentSplenectomylaparoscopic splenectomyAsymptomaticPerioperative Care03 medical and health sciencesYoung AdultmedicineHumansThrombusPortal vein thrombosiAgedRetrospective Studiesbusiness.industryRetrospective cohort studycomputed tomographyOdds ratiomedicine.diseaseSurgerySettore MED/18 - Chirurgia GeneraleLogistic ModelsSplenic veinSplenic VeinAsymptomatic DiseasesSurgeryLaparoscopybusinessComplicationTomography X-Ray ComputedFollow-Up StudiesSurgery
researchProduct